Clinical Trial Update: A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy

View source ↗

Summary

A completed ClinicalTrials.gov study evaluating nivolumab in patients with advanced non-small cell lung cancer in France after prior chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer | Status: COMPLETED